Skip to main content
Erschienen in: Urolithiasis 6/2003

01.12.2003 | Original Paper

Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis

verfasst von: Armando Luis Negri, Rodolfo Spivacow, Elisa Del Valle, Erich Fradinger, Alicia Marino, Jose Ruben Zanchetta

Erschienen in: Urolithiasis | Ausgabe 6/2003

Einloggen, um Zugang zu erhalten

Abstract

Although urine phosphate loss has been associated with hypercalciuria, it is debated how frequently renal phosphate leak is present in hypercalciuric patients. We reviewed the records of 100 consecutive adult patients who were diagnosed with idiopathic hypercalciuria and calcium urolithiasis, searching for the presence of renal phosphate leak. The renal phosphate threshold, normalized for the glomerular filtration rate (TmPO4/GFR), of the hypercalciuric patients followed a normal distribution and had a good correlation with serum phosphate (r=0.77; p<0.0001). There were no correlations between TmPO4/GFR and urinary calcium or between serum phosphorus and urinary calcium. We found only nine patients (9%) with renal phosphate leak. These patients had a mean TmPO4/GFR of 2.19 mg% (0.70 mmol/l) and serum phosphorus of 2.65 mg% (0.85 mmol/l). Nevertheless, urinary calcium was not significantly different between patients with or without low TmPO4/GFR. We conclude that renal phosphate leak is an infrequent finding in patients with idiopathic hypercalciuria and is not associated with a higher urinary calcium loss.
Literatur
1.
Zurück zum Zitat Barilla SE, Zerwekh JE, Pak CYC (1979) A critical evaluation of the role of phosphate in the pathogenesis of absorptive hypercalciuria. Min Electrolyte Metab 2: 302 Barilla SE, Zerwekh JE, Pak CYC (1979) A critical evaluation of the role of phosphate in the pathogenesis of absorptive hypercalciuria. Min Electrolyte Metab 2: 302
2.
Zurück zum Zitat Breslau NA, Preminger MG, Adams BV, Oty J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75: 1446PubMed Breslau NA, Preminger MG, Adams BV, Oty J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75: 1446PubMed
3.
Zurück zum Zitat Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate super saturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57: 550CrossRefPubMed Bushinsky DA, Parker WR, Asplin JR (2000) Calcium phosphate super saturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57: 550CrossRefPubMed
4.
Zurück zum Zitat Friedlander G, Couette S, Coureau C, Amiel C (1992) Mechanisms whereby extracellular adenosine 3', 5'-momophosphate inhibits phosphate transport in cultured opossum kidney cells and in the rat kidney. J Clin Invest 90: 848PubMed Friedlander G, Couette S, Coureau C, Amiel C (1992) Mechanisms whereby extracellular adenosine 3', 5'-momophosphate inhibits phosphate transport in cultured opossum kidney cells and in the rat kidney. J Clin Invest 90: 848PubMed
5.
Zurück zum Zitat Gray RW, Wilz DR, Caldas AE, Lemann J Jr (1977) The importance of phosphate in regulating plasma 1,25-(OH) 2D levels in humans: studies of healthy subjects, in calcium stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 45: 299PubMed Gray RW, Wilz DR, Caldas AE, Lemann J Jr (1977) The importance of phosphate in regulating plasma 1,25-(OH) 2D levels in humans: studies of healthy subjects, in calcium stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 45: 299PubMed
6.
Zurück zum Zitat Lemann J Jr (1992) Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism. Raven Press, New York, p 685 Lemann J Jr (1992) Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism. Raven Press, New York, p 685
7.
Zurück zum Zitat Lerolle N, Lantz B, Paillard F et al (2002) Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med 113: 99CrossRefPubMed Lerolle N, Lantz B, Paillard F et al (2002) Risk factors for nephrolithiasis in patients with familial idiopathic hypercalciuria. Am J Med 113: 99CrossRefPubMed
8.
Zurück zum Zitat Michaut P, Prié D, Amiel C, Friedlander G (1994) Dipyridamole for renal phosphate leak? N Engl J Med 331: 58CrossRef Michaut P, Prié D, Amiel C, Friedlander G (1994) Dipyridamole for renal phosphate leak? N Engl J Med 331: 58CrossRef
9.
Zurück zum Zitat Pak CYC (1991) Etiology and treatment of urolithiasis. Am J Kidney Dis 18: 624PubMed Pak CYC (1991) Etiology and treatment of urolithiasis. Am J Kidney Dis 18: 624PubMed
10.
Zurück zum Zitat Pak CYC, Britton F, Peterson R et al (1980) Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 69: 19PubMed Pak CYC, Britton F, Peterson R et al (1980) Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 69: 19PubMed
11.
Zurück zum Zitat Prié D, Blanchet FB, Essig M, Jourdain J-P, Friedlander G (1998) Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold. J Am Soc Nephrol 9: 1264PubMed Prié D, Blanchet FB, Essig M, Jourdain J-P, Friedlander G (1998) Dipyridamole decreases renal phosphate leak and augments serum phosphorus in patients with low renal phosphate threshold. J Am Soc Nephrol 9: 1264PubMed
12.
Zurück zum Zitat Prié D, Ravery V, Boccon-Gibod L, Friedlander G (2001) Frequency of renal phosphate leak among patients with calcium nephrolithiasis, Kidney Int 60: 272 Prié D, Ravery V, Boccon-Gibod L, Friedlander G (2001) Frequency of renal phosphate leak among patients with calcium nephrolithiasis, Kidney Int 60: 272
13.
Zurück zum Zitat Sakhaee K, Nicar MJ, Brater DC, Pak CYC (1985) Exaggerated natriuretic and calciuric response to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria. J Clin Endocrinol Metab 61: 825PubMed Sakhaee K, Nicar MJ, Brater DC, Pak CYC (1985) Exaggerated natriuretic and calciuric response to hydrochlorothiazide in renal hypercalciuria but not in absorptive hypercalciuria. J Clin Endocrinol Metab 61: 825PubMed
14.
Zurück zum Zitat Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2: 309PubMed Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2: 309PubMed
15.
Zurück zum Zitat Williams CP, Child DP, Hudson PR et al (1995) Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatments. J Clin Pathol 49: 881 Williams CP, Child DP, Hudson PR et al (1995) Inappropriate phosphate excretion in idiopathic hypercalciuria: the key to a common cause and future treatments. J Clin Pathol 49: 881
Metadaten
Titel
Renal phosphate leak in patients with idiopathic hypercalciuria and calcium nephrolithiasis
verfasst von
Armando Luis Negri
Rodolfo Spivacow
Elisa Del Valle
Erich Fradinger
Alicia Marino
Jose Ruben Zanchetta
Publikationsdatum
01.12.2003
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 6/2003
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-003-0353-y

Weitere Artikel der Ausgabe 6/2003

Urolithiasis 6/2003 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.